*  Exposure Controls/Personal Protection  *
Respiratory Protection:NONE REQUIRED. NIOSH/MSHA APPROVED RESPIRATOR
    APPROPRIATE FOR EXPOSURE OF CONCERN .
Ventilation:NO SPECIAL PROVISIONS REQUIRED.
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EFTS OF OVEREXP: DIFFICULTIES), REDUCED HEART RATE AND MUSCLE RIGIDITY.
    OTHER ADVERSE RXNS INCL CHANGES IN BLOOD PRESS, DIZZ, BLURRED
    VISION, NAUSEA, EMESIS, LARYNGOSPASM & PERSPIRATION. OPIOID ANALGE
    SICS PRODUCE EUPHORIA, MIOSIS (CONSTRICTION OF PUPILS), REDUCED
    HEART RATE & BRONCHOCONSTRICTION. (ING 2)
*  Product Identification  *
*  Composition/Information on Ingredients  *
Ingred Name:PROPIONANILIDE, N-(1-PHENETHYL-4-PIPERIDYL)-, CITRATE
    (1:1); (FENTANYL CITRATE).
OSHA PEL:N/K 
ACGIH TLV:N/K 
Ingred Name:SUPP DATA:OVERDOSE PRODUCES THE SAME EFFECTS WHICH IF NOT
    TREATED CAN LEAD TO CESSATION OF BRTHG UNCON & CARDIAC ARREST.
*  Hazards Identification  *
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NOOSHA:NO
Health Hazards Acute and Chronic:FENTANYL CITRATE IS A POTENT NARCOTIC
    THERAPEUTICALLY TO PRODUCE ANALGESIA (PAIN RELIEF) & SEDATION.
    FENTANYL CITRATE CAN CAUSE RESPIR ATORY DEPRESSION, REDUCED HEART
    RATE & MUSCLE RIGIDITY. IN REPROD STUDIES IN RATS FENTANYL CITRATE
    (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ: ADMIN RESULTED IN DECREASE IN
    0.3 TIMES THE HUMAN DOSE. FENTANYL CITRATE CAN PRODUCE DRUG
    DEPENDENCE OF THE MORPHINE TYPE  AND HAS POTENTIAL FOR BEING
    ABUSED. SIGNS & SYMPS: CLINICALLY, OVEREXP CAN PRODUCE RESP DEPRESS
    (BRTHG (SUPP DATA)
Medical Cond Aggravated by Exposure:CNDTNS ASSOCIATED W/IMPAIRED RESP,
    LIVER OR KIDNEY DYSFUNCTION, HEART DISEASE & CONCURRENT USE OF CNS
    DEPRESSANT DRUGS.
*  First Aid Measures  *
First Aid:INHAL:REMOVE FROM SOURCE OF EXPOSURE. SKIN/ EYE: FLUSH
    SIGNS OF TOX OCCUR, SEEK MED ATTN. SPECIFIC NARCOTIC ANTAGONISTS,
    E.G., NALORPHIN E HYDROBROMIDE OR NALOXONE HYDROCHLORIDE, &
    ANTIDOTES FOR RESP DEPRESS PRODUCED BY FENTANYL CITRATE. PROVIDE
    SYMPTOMATIC/SUPPORTIVE CARE AS NEC. INGEST: GET MD IMMED .
*  Fire Fighting Measures  *
Flash Point:NON-FLAMMABLE
Extinguishing Media:EXTINGUISHING MEDIA SUITABLE FOR SURROUNDING FIRE .
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA AND FULL
    PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:NONE SPECIFIED BY MANUFACTURER.
*  Accidental Release Measures  *
Spill Release Procedures:ABSORB WITH SUITABLE MATERIAL, FLUSH WITH
    WATER AND METHANOL.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.
*Handling and Storage  *
Handling and Storage Precautions:NONE SPECIFIED BY MANUFACTURER.
Other Precautions:NONE SPECIFIED BY MANUFACTURER.
*  Physical/Chemical Properties  *
HCC:T3
Boiling Pt:B.P. Text:WATER
Spec Gravity:WATER
pH:4-7.5
Solubility in Water:AQUEOUS SOLUTION
Appearance and Odor:CLEAR LIQUID.
Percent Volatiles by Volume:NEGLIG
*  Stability and Reactivity Data  *
Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:WHEN HEATED TO DECOMPOSITION, IT EMITS
    TOXIC FUMES OF OXIDES OF NITROGEN.
*  Disposal Considerations  *
Waste Disposal Methods:DISPOSE OF SOLUTION IN SEWER. BURY IN LANDFILL.
    DISPOSE OF IN ACCORDANCE WITH LOCAL, STATE AND FEDERAL REGULATIONS
    .
